Form 4: Guardant Health Director Vests Shares

Myrtle S. Potter, a Director at Guardant Health, Inc., reported the vesting of 69 shares of common stock.

Summary

• Myrtle S. Potter, a Director at Guardant Health, Inc. (GH), reported the acquisition of 69 shares of common stock.
• The transaction occurred on October 15, 2025, and involved the vesting of Restricted Stock Units (RSUs) at a price of $0 per share.
• Following this vesting, Ms. Potter's beneficial ownership in Guardant Health stands at 18,350 shares of common stock.
• The RSUs began vesting on October 15, 2022, with 25% vesting initially and the remaining 75% vesting in equal monthly installments over the subsequent three years.

Sentiment

Score: 6

Explanation: The vesting of shares by a director is a neutral to slightly positive event, indicating continued alignment of interests with shareholders, though it's a compensation event rather than an open market purchase.

Positives

• The vesting of 69 shares increases Director Myrtle S. Potter's direct ownership, aligning her interests with those of Guardant Health shareholders.
• Ms. Potter maintains a substantial beneficial ownership of 18,350 shares in the company.

Negatives

• The filing does not contain any information that would be considered negative for Guardant Health.

Risks

• This Form 4 filing is a statutory report of insider transaction activity and does not disclose company-specific risks.

Future Outlook

The filing does not provide any forward-looking statements or guidance regarding Guardant Health's future performance or strategic direction.

Management Comments

• The filing is a statutory report of insider transactions and does not contain direct quotes or paraphrased statements from company management.

Industry Context

This Form 4 filing is a routine disclosure of insider share ownership changes and does not provide information to analyze broader industry trends or competitor activities.

Comparison to Industry Standards

• This filing is a routine insider transaction report and does not contain information suitable for comparison to global benchmarks or specific comparable companies/projects.

Stakeholder Impact

• Shareholders: The increase in director ownership, even through vesting, generally signals continued alignment of management interests with shareholder value.

Next Steps

• The filing indicates a vesting schedule for Restricted Stock Units, with the remaining 75% vesting in substantially equal monthly installments over a three-year period from October 15, 2022. This implies future vesting events will occur.

Key Dates

Keywords

Guardant Health, GH, Myrtle S. Potter, Form 4, Insider Trading, Restricted Stock Units, RSU vesting, Director, Beneficial Ownership